Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

S-P China move

This article was originally published in The Tan Sheet

Executive Summary

Schering-Plough establishes Shanghai Schering-Plough Pharmaceutical Co., Ltd., as a wholly owned operation in Shanghai, expanding its presence in the Chinese market, the firm says Aug. 12. The new operation is the result of S-P's acquisition of its former joint venture partners' shares and is part of S-P's "long-term global geographic expansion strategy," Chairman and CEO Fred Hassan says in a release. The company entered into an agreement in 1994 with two local joint-venture partners in China, Shanghai Pharmaceutical Industry Co., Ltd., and Shanghai Pharmaceutical Group Co., Ltd., to manufacture, market and distribute allergy and skin-care products in the country. Hassan says establishing the Shanghai operation "represents another step in our journey to transform Schering-Plough into a global high-performance health care company"...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS102011

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel